Joseph Pantginis
Stock Analyst at HC Wainwright & Co.
(1.87)
# 3,120
Out of 4,896 analysts
788
Total ratings
32.75%
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Joseph Pantginis
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
CAPR Capricor Therapeutics | Maintains: Buy | $77 → $24 | $7.64 | +214.14% | 24 | Jul 11, 2025 | |
TVTX Travere Therapeutics | Assumes: Buy | $30 | $16.46 | +82.26% | 1 | Jul 1, 2025 | |
PDSB PDS Biotechnology | Reiterates: Buy | $13 | $1.24 | +948.39% | 32 | Jul 1, 2025 | |
EWTX Edgewise Therapeutics | Initiates: Buy | $42 | $13.85 | +203.25% | 1 | Jun 30, 2025 | |
VKTX Viking Therapeutics | Reiterates: Buy | $102 | $31.11 | +227.87% | 33 | Jun 25, 2025 | |
PHIO Phio Pharmaceuticals | Reiterates: Buy | $14 | $2.31 | +506.06% | 2 | Jun 25, 2025 | |
KRYS Krystal Biotech | Reiterates: Buy | $240 | $148.17 | +61.98% | 31 | Jun 24, 2025 | |
CDTX Cidara Therapeutics | Maintains: Buy | $41 → $53 | $50.54 | +4.88% | 2 | Jun 24, 2025 | |
LXRX Lexicon Pharmaceuticals | Reiterates: Buy | $4 | $1.08 | +270.37% | 22 | Jun 24, 2025 | |
ATNM Actinium Pharmaceuticals | Reiterates: Buy | $4 | $1.52 | +163.16% | 31 | Jun 24, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.03 | +773.79% | 12 | Jun 23, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $0.55 | +627.14% | 2 | Jun 18, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $1.19 | +1,244.54% | 29 | Jun 17, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $6 | $2.51 | +139.04% | 1 | Jun 17, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $26 | $4.70 | +453.19% | 14 | Jun 17, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $22.91 | +118.29% | 35 | Jun 16, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $6.36 | +151.57% | 20 | Jun 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.66 | +502.41% | 3 | Jun 11, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $35 | $5.30 | +560.38% | 9 | Jun 4, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.61 | - | 4 | Jun 2, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $104 | $27.38 | +279.84% | 24 | May 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $9 | $2.22 | +305.41% | 15 | May 19, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $17 | $1.83 | +828.96% | 1 | May 19, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $32 | $12.92 | +147.68% | 6 | May 16, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $15 | $0.42 | +3,514.46% | 15 | May 16, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $2.00 | +700.00% | 12 | May 15, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $250 | $7.15 | +3,396.50% | 3 | May 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $20 | $1.87 | +969.52% | 28 | May 9, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $9 | $1.13 | +696.46% | 1 | May 8, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $18 | $2.00 | +800.00% | 30 | May 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 → $15 | $7.89 | +90.11% | 9 | Apr 30, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $6.28 | +536.94% | 26 | Apr 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5.75 → $4.5 | $1.42 | +216.90% | 22 | Apr 25, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.68 | +631.85% | 16 | Apr 25, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $24 | $2.70 | +788.89% | 18 | Apr 21, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $120 | $37.01 | +224.24% | 48 | Apr 21, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $16 | $6.95 | +130.22% | 19 | Apr 10, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $3.98 | - | 9 | Apr 9, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $31 | $3.59 | +763.51% | 31 | Apr 8, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $0.71 | +1,590.14% | 1 | Apr 3, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.82 | - | 18 | Mar 27, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $37 | $10.20 | +262.60% | 17 | Mar 21, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $2.03 | +441.87% | 7 | Mar 19, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $57 | $18.88 | +201.91% | 26 | Mar 5, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $21 | $7.69 | +173.08% | 1 | Feb 4, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $1.73 | +1,056.07% | 14 | Jan 15, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $2.39 | +946.03% | 16 | Dec 18, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $2.71 | +453.51% | 16 | Dec 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $26 | $1.89 | +1,275.66% | 3 | Nov 18, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $3.91 | +540.07% | 4 | Oct 2, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $2.65 | +3,673.58% | 7 | May 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.32 | - | 6 | Dec 1, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $32 | $1.71 | +1,771.35% | 4 | Feb 25, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $30 | $2.37 | +1,165.82% | 2 | Nov 3, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.27 | - | 2 | Jan 31, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $18 → $33 | $37.09 | -11.02% | 2 | Nov 14, 2017 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 → $78 | $4.69 | +1,564.89% | 1 | Mar 24, 2017 |
Capricor Therapeutics
Jul 11, 2025
Maintains: Buy
Price Target: $77 → $24
Current: $7.64
Upside: +214.14%
Travere Therapeutics
Jul 1, 2025
Assumes: Buy
Price Target: $30
Current: $16.46
Upside: +82.26%
PDS Biotechnology
Jul 1, 2025
Reiterates: Buy
Price Target: $13
Current: $1.24
Upside: +948.39%
Edgewise Therapeutics
Jun 30, 2025
Initiates: Buy
Price Target: $42
Current: $13.85
Upside: +203.25%
Viking Therapeutics
Jun 25, 2025
Reiterates: Buy
Price Target: $102
Current: $31.11
Upside: +227.87%
Phio Pharmaceuticals
Jun 25, 2025
Reiterates: Buy
Price Target: $14
Current: $2.31
Upside: +506.06%
Krystal Biotech
Jun 24, 2025
Reiterates: Buy
Price Target: $240
Current: $148.17
Upside: +61.98%
Cidara Therapeutics
Jun 24, 2025
Maintains: Buy
Price Target: $41 → $53
Current: $50.54
Upside: +4.88%
Lexicon Pharmaceuticals
Jun 24, 2025
Reiterates: Buy
Price Target: $4
Current: $1.08
Upside: +270.37%
Actinium Pharmaceuticals
Jun 24, 2025
Reiterates: Buy
Price Target: $4
Current: $1.52
Upside: +163.16%
Jun 23, 2025
Reiterates: Buy
Price Target: $9
Current: $1.03
Upside: +773.79%
Jun 18, 2025
Reiterates: Buy
Price Target: $4
Current: $0.55
Upside: +627.14%
Jun 17, 2025
Reiterates: Buy
Price Target: $16
Current: $1.19
Upside: +1,244.54%
Jun 17, 2025
Assumes: Buy
Price Target: $6
Current: $2.51
Upside: +139.04%
Jun 17, 2025
Reiterates: Buy
Price Target: $26
Current: $4.70
Upside: +453.19%
Jun 16, 2025
Reiterates: Buy
Price Target: $50
Current: $22.91
Upside: +118.29%
Jun 13, 2025
Reiterates: Buy
Price Target: $16
Current: $6.36
Upside: +151.57%
Jun 11, 2025
Reiterates: Buy
Price Target: $10
Current: $1.66
Upside: +502.41%
Jun 4, 2025
Reiterates: Buy
Price Target: $35
Current: $5.30
Upside: +560.38%
Jun 2, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.61
Upside: -
May 28, 2025
Reiterates: Buy
Price Target: $104
Current: $27.38
Upside: +279.84%
May 19, 2025
Maintains: Buy
Price Target: $7 → $9
Current: $2.22
Upside: +305.41%
May 19, 2025
Assumes: Buy
Price Target: $17
Current: $1.83
Upside: +828.96%
May 16, 2025
Reiterates: Buy
Price Target: $32
Current: $12.92
Upside: +147.68%
May 16, 2025
Maintains: Buy
Price Target: $21 → $15
Current: $0.42
Upside: +3,514.46%
May 15, 2025
Reiterates: Buy
Price Target: $16
Current: $2.00
Upside: +700.00%
May 13, 2025
Reiterates: Buy
Price Target: $250
Current: $7.15
Upside: +3,396.50%
May 9, 2025
Maintains: Buy
Price Target: $32 → $20
Current: $1.87
Upside: +969.52%
May 8, 2025
Assumes: Buy
Price Target: $9
Current: $1.13
Upside: +696.46%
May 6, 2025
Maintains: Buy
Price Target: $40 → $18
Current: $2.00
Upside: +800.00%
Apr 30, 2025
Reiterates: Buy
Price Target: $11 → $15
Current: $7.89
Upside: +90.11%
Apr 28, 2025
Reiterates: Buy
Price Target: $40
Current: $6.28
Upside: +536.94%
Apr 25, 2025
Maintains: Buy
Price Target: $5.75 → $4.5
Current: $1.42
Upside: +216.90%
Apr 25, 2025
Reiterates: Buy
Price Target: $5
Current: $0.68
Upside: +631.85%
Apr 21, 2025
Reiterates: Buy
Price Target: $24
Current: $2.70
Upside: +788.89%
Apr 21, 2025
Reiterates: Buy
Price Target: $120
Current: $37.01
Upside: +224.24%
Apr 10, 2025
Downgrades: Neutral
Price Target: $16
Current: $6.95
Upside: +130.22%
Apr 9, 2025
Reiterates: Neutral
Price Target: n/a
Current: $3.98
Upside: -
Apr 8, 2025
Reiterates: Buy
Price Target: $31
Current: $3.59
Upside: +763.51%
Apr 3, 2025
Initiates: Buy
Price Target: $12
Current: $0.71
Upside: +1,590.14%
Mar 27, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.82
Upside: -
Mar 21, 2025
Reiterates: Buy
Price Target: $37
Current: $10.20
Upside: +262.60%
Mar 19, 2025
Reiterates: Buy
Price Target: $11
Current: $2.03
Upside: +441.87%
Mar 5, 2025
Reiterates: Buy
Price Target: $57
Current: $18.88
Upside: +201.91%
Feb 4, 2025
Maintains: Buy
Price Target: $8 → $21
Current: $7.69
Upside: +173.08%
Jan 15, 2025
Reiterates: Buy
Price Target: $20
Current: $1.73
Upside: +1,056.07%
Dec 18, 2024
Reiterates: Buy
Price Target: $25
Current: $2.39
Upside: +946.03%
Dec 11, 2024
Reiterates: Buy
Price Target: $15
Current: $2.71
Upside: +453.51%
Nov 18, 2024
Maintains: Buy
Price Target: $24 → $26
Current: $1.89
Upside: +1,275.66%
Oct 2, 2024
Reiterates: Buy
Price Target: $25
Current: $3.91
Upside: +540.07%
May 16, 2024
Reiterates: Buy
Price Target: $100
Current: $2.65
Upside: +3,673.58%
Dec 1, 2021
Downgrades: Neutral
Price Target: n/a
Current: $2.32
Upside: -
Feb 25, 2021
Maintains: Buy
Price Target: $36 → $32
Current: $1.71
Upside: +1,771.35%
Nov 3, 2020
Upgrades: Buy
Price Target: $30
Current: $2.37
Upside: +1,165.82%
Jan 31, 2018
Downgrades: Neutral
Price Target: n/a
Current: $1.27
Upside: -
Nov 14, 2017
Assumes: Buy
Price Target: $18 → $33
Current: $37.09
Upside: -11.02%
Mar 24, 2017
Reiterates: Buy
Price Target: $60 → $78
Current: $4.69
Upside: +1,564.89%